Search
for
Sort by
Research 31–60 of 1000+
- LAM/TSC Cell Migration to Uterus in an Experimental Model of Lymphangioleiomyomatosis. Regulation by Anti-Epidermal Growth Factor Receptor Antibody and Rapamycin
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery
- Nanomaterial-Based Therapy for Wound Healing
- Recent advances on skin‐resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti‐aging and cancer therapies
- Abstracts
- Pathological Skin Scarring: From Mechanism to Targeted Local Therapy
- Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies
- Quantifying extracellular vesicle heterogeneity: the effect of process conditions on protein cargo for skin therapy
- Acne and acneiform eruptions
- Therapeutic potential of <i>Asiaticoside</i> in wound healing after endoscopic submucosal dissection (ESD)
- Chemistry, Pharmacology and Therapeutic Potential of Decursin: A Promising Natural Lead for New Drug Discovery and Development
- New Plant Extracts Exert Complementary Anti‐Hair Loss Properties in Human In Vitro and Ex Vivo Models
- Cellular senescence and polycystic ovary syndrome: mechanisms and therapeutic strategies from a new perspective
- GSDMA deficiency impairs cutaneous squamous cell carcinoma growth
- Pathological Mechanisms Involved in Epidermolysis Bullosa Simplex: Current Knowledge and Therapeutic Perspectives
- Selenium Compounds and Their Bioactivities: Molecular Mechanisms and Prospects for Functional Food and Therapeutic Applications
- Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Successful treatment of epidermal growth factor receptor inhibitor–induced alopecia with doxycycline
- Network pharmacology, molecular docking, and dynamics reveal the mechanisms of Hejie Shengfa Decoction against alopecia areata
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Erlotinib-Induced Skin Inflammation Is IL-1 Mediated in KC-Tie2 Mice and Human Skin Organ Culture
- When bugs and drugs conspire: driving acneiform skin toxicity
- Hair follicle stem cells and the collapse of self-tolerance in alopecia: the interplay of barrier function, the microbiome, and immunity
- Persistent hair growth during treatment with the EGFR inhibitor erlotinib
- Vitex negundo: A comprehensive review of phytoconstituents, their derivatives, and therapeutic applications
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Malignant epithelial tumors: Part II. Therapy and prevention
- 3D spheroid culture synchronizes heterogeneous MSCs into an immunomodulatory phenotype with enhanced anti-inflammatory effects